Search Results for: elsevier

Oh, the gall(stones): A journal should retract a paper on reiki and pain, says a critic

Talk about missing the trees for the, ahem, forest plots. A researcher is accusing an Elsevier journal of refusing to retract a study that depends in large part on a flawed reference.  The paper, “The effect of Acupressure and Reiki application on Patient’s pain and comfort level after laparoscopic cholecystectomy: A randomized controlled trial,” appeared … Continue reading Oh, the gall(stones): A journal should retract a paper on reiki and pain, says a critic

Clinical trial paper that made anemia drug look safer than it is will be retracted

A study that a pharmaceutical company admitted last month included manipulated data will be retracted, Retraction Watch has learned. The paper, “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis,” was published in Kidney International Reports in December 2020. The study analyzed data from a clinical trial for roxadustat, a … Continue reading Clinical trial paper that made anemia drug look safer than it is will be retracted

Years after faked peer review concerns surfaced, journals are still falling for it

A group of authors has lost a pair of papers in a computing journal for monkeying with the peer review process.  The first author on both articles was Mohamed Abdel-Basset of the Department of Operations Research in the Faculty of Computers and Informatics at Zagazig University, in Sharqiya. Mai Mohamad, also of Zagazig, is the … Continue reading Years after faked peer review concerns surfaced, journals are still falling for it

Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

One of China’s leading scientists in the fight against COVID-19 failed to disclose ties to a pharmaceutical company in a paper stemming from a clinical trial, Retraction Watch has learned. A co-author on the paper is married to the daughter of that pharmaceutical company’s founder, who herself sits on the firm’s board of directors.  Nanshan … Continue reading Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Editor declines to correct paper with duplicated image after earlier … Continue reading Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results

Editor declines to correct paper with duplicated image after earlier study disappears

Possession is nine-tenths of the law — at least, it seems, for one journal editor, who is refusing to retract a study despite learning that one of its images previously appeared in another journal. The reason? The other study has been removed from the web.  The paper is among 40 articles in Construction and Building … Continue reading Editor declines to correct paper with duplicated image after earlier study disappears

Palmitoleic acid paper pulled for data concerns

A journal has retracted the 2014 report of a clinical trial of a supplement touted as a way to reduce the risk of cardiovascular disease after beginning to suspect that the data were not reliable.  The study, “Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled … Continue reading Palmitoleic acid paper pulled for data concerns

Pharma company demands retraction, damages in lawsuit against journal

A drug company that manufactures a painkiller used for surgery patients has sued an anesthesiology journal along with its editor and publisher and the authors of articles that it says denigrated its product unfairly. In a complaint filed yesterday in U.S. District Court in New Jersey, Pacira Biosciences claims that “In the February 2021 issue … Continue reading Pharma company demands retraction, damages in lawsuit against journal

One in six of the papers you cite in a review has been retracted. What do you do?

The author of a 2014 review article about the role of vitamin D in Parkinson’s disease has alerted readers to the fact that roughly one-sixth of her references have since been retracted. But she and the journal are not retracting the review itself.  The paper, “A review of vitamin D and Parkinson’s disease,” appeared in … Continue reading One in six of the papers you cite in a review has been retracted. What do you do?

Weekend reads: Faked data in psychology; publishing in predatory journals = misconduct?; how scientists take criticism

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Seven barred from research after plagiarism, duplications in eleven papers … Continue reading Weekend reads: Faked data in psychology; publishing in predatory journals = misconduct?; how scientists take criticism